Catalyst Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368K | Sell |
7,953
-398
| -5% | -$18.4K | 0.04% | 204 |
|
|
2025
Q1 | $509K | Buy |
8,351
+642
| +8% | +$39.2K | 0.09% | 144 |
|
|
2024
Q4 | $436K | Buy |
7,709
+1,490
| +24% | +$84.3K | 0.08% | 156 |
|
|
2024
Q3 | $322K | Buy |
6,219
+1,259
| +25% | +$65.1K | 0.06% | 191 |
|
|
2024
Q2 | $206K | Sell |
4,960
-1,621
| -25% | -$67.3K | 0.05% | 237 |
|
|
2024
Q1 | $315K | Buy |
6,581
+637
| +11% | +$30.5K | 0.08% | 164 |
|
|
2023
Q4 | $305K | Sell |
5,944
-1,628
| -22% | -$83.5K | 0.09% | 162 |
|
|
2023
Q3 | $439K | Buy |
7,572
+1,382
| +22% | +$80.2K | 0.14% | 109 |
|
|
2023
Q2 | $396K | Buy |
6,190
+189
| +3% | +$12.1K | 0.14% | 106 |
|
|
2023
Q1 | $416K | Buy |
6,001
+145
| +2% | +$10.1K | 0.18% | 83 |
|
|
2022
Q4 | $421K | Buy |
+5,856
| New | +$421K | 0.22% | 70 |
|